CRE Recombinase (CRE) (AA 287-314), (C-Term) antibody
Quick Overview for CRE Recombinase (CRE) (AA 287-314), (C-Term) antibody (ABIN2793617)
Target
See all CRE Recombinase (CRE) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 287-314, C-Term
-
Purpose
- Rabbit Anti-Human CREM (C-term) Antibody
-
Immunogen
- This CREM antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 287-314 amino acids from the C-terminal region of human CREM.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
-
Western Blot, Flow Cytometry
Recommended Dilutions
WB: 1:1000, FC: 1:10-50Western blot analysis of CREM Antibody (C-term) .FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 2.0 mg/mL
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- 2-8°C (short-term), -20°C (long-term)
-
-
- CRE Recombinase (CRE)
-
Alternative Name
- CRE
-
Target Type
- Phage Protein
-
Background
-
Target Description: CREM is a bZIP transcription factor that binds to the cAMP responsive element found in many viral and cellular promoters. It is an important component of cAMP-mediated signal transduction during the spermatogenetic cycle, as well as other complex processes.
Gene Symbol: CREM
-
Molecular Weight
- 38940 Da
-
Gene ID
- 1390
-
UniProt
- Q03060
Target
-